In the not-so-distant future, will playing video games be part of the prescription for treating children with attention-deficit/hyperactivity disorder (ADHD)? That’s what one company, Akili Interactive Labs, Inc., is hoping for.
The Boston-based company just raised $30.5 million in venture capital funding to support clinical development for a game called “Project: EVO.” The developers hope it could be a game changer in helping people with ADHD. Akili aims to apply for FDA clearance and launch the product in 2017, according to a press release announcing the funding.
